GAMMA Investing LLC increased its position in Semler Scientific Inc. (NASDAQ:SMLR - Free Report) by 49,133.3% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 7,385 shares of the company's stock after purchasing an additional 7,370 shares during the quarter. GAMMA Investing LLC owned approximately 0.08% of Semler Scientific worth $267,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Capital International Investors acquired a new stake in shares of Semler Scientific during the 4th quarter worth approximately $30,813,000. Susquehanna Advisors Group Inc. acquired a new position in Semler Scientific in the fourth quarter valued at approximately $26,928,000. Driehaus Capital Management LLC bought a new position in Semler Scientific in the fourth quarter valued at approximately $10,122,000. Shariaportfolio Inc. grew its holdings in Semler Scientific by 4.5% during the 4th quarter. Shariaportfolio Inc. now owns 160,453 shares of the company's stock worth $8,664,000 after acquiring an additional 6,837 shares during the period. Finally, Geode Capital Management LLC grew its holdings in Semler Scientific by 3.3% during the 4th quarter. Geode Capital Management LLC now owns 140,423 shares of the company's stock worth $7,584,000 after acquiring an additional 4,464 shares during the period. 49.37% of the stock is owned by institutional investors.
Semler Scientific Trading Down 2.0%
SMLR traded down $0.85 during midday trading on Wednesday, reaching $41.04. 1,203,731 shares of the company were exchanged, compared to its average volume of 541,960. The stock has a market capitalization of $457.60 million, a P/E ratio of -15.72 and a beta of 1.42. Semler Scientific Inc. has a one year low of $21.77 and a one year high of $81.56. The stock's 50-day simple moving average is $35.67 and its 200 day simple moving average is $44.23. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.51 and a current ratio of 0.52.
Semler Scientific (NASDAQ:SMLR - Get Free Report) last released its quarterly earnings data on Tuesday, May 13th. The company reported ($0.76) earnings per share for the quarter. The firm had revenue of $8.84 million for the quarter. Semler Scientific had a positive return on equity of 19.75% and a negative net margin of 60.69%.
Analysts Set New Price Targets
Separately, Wall Street Zen downgraded Semler Scientific from a "buy" rating to a "sell" rating in a research note on Thursday, May 22nd.
Check Out Our Latest Research Report on Semler Scientific
Semler Scientific Profile
(
Free Report)
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
Recommended Stories
Before you consider Semler Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Semler Scientific wasn't on the list.
While Semler Scientific currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
